{"name":"Invion, Inc.","slug":"invion-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ala-Cpn10","genericName":"Ala-Cpn10","slug":"ala-cpn10","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Ala-Cpn10","genericName":"Ala-Cpn10","slug":"ala-cpn10","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPOVR2LWE0bDg1Rk03XzZmZDVFaFg5ejhtNHlvb09mMTZ6SHdvMThzUko3Y2JTOFFTXzEtbjEzeHlQcWVHNnJoMlBGRTBlSEdLMDhFSHlYaTRaM3ZhdWptTmo5Unk1X0dvaFBaRjlXcVVBUUpsczRFaUxUMjJNX1VteEM0RE5paVcxa0VuQkpaY0VuVGxBV2JtamhxanVyMVVDMG1Z?oc=5","date":"2026-02-14","type":"pipeline","source":"ABC News","summary":"Companies that have suspended operations in Russia over invasion of Ukraine - ABC News","headline":"Companies that have suspended operations in Russia over invasion of Ukraine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQRTV2cHFhZm5BYlRoM3I2WVNfb2kxWEhNbllDTmhiSF9Lbm9BNXYweGVsaXdEcmVMZXlTam56TG42ZUFBUWlQMk9XY2UwVGdVM2dVcWFscVlFUlpMcEFrdDZLSS05RVNNS1BLZDhhTm5CanN0cHhnSXZYemN3OEVPODRVTmtRR0JqNHc?oc=5","date":"2026-01-01","type":"pipeline","source":"Investing News Network","summary":"Inside the ASX Biotech Boom: What’s Fuelling the Next Wave - Investing News Network","headline":"Inside the ASX Biotech Boom: What’s Fuelling the Next Wave","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5qeXcyd0ZVMEd6ZnUwdndKZVVOZ05sMGo2cDFORE0yZkJZd3NIMzZuaVpGVkZJV2hXSlhyX0E0cUhTN1M2R0RJYWh2dVdTYi0x?oc=5","date":"2025-10-30","type":"pipeline","source":"smallcaps.com.au","summary":"Insights: Invion Ltd (ASX:IVX) - smallcaps.com.au","headline":"Insights: Invion Ltd (ASX:IVX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxQRVY0YjhqQ1BSTW9qVTkzV3huNUFueGR1V3FibTE2azc5UFFILThvSjZaNVB0VkVDcXpva0Z3TlZaYzR0Z0U1V29tY0E1YnFaREIwVER3Zl92d05jZUtlY0xOYTdnZ19RLXFRdnd3cHplaVdDZWk0YjVaNnF3NE5FclFkYzR4TDRKejdvd3pudWhwWEtEblVfY1FKU2tMTHJpRVFoQ0ViaWFvN3lqenNvS0pqazl5Xy1fU3lEckQ3X1lfYmd1dGgzUE1iZnlFNDNuWW5Cd2ZwNDBPQzBRSkJyT3ZSRGVLbUdiS0NnV0lWOVdzaldXeXNKbFFxcnk4MmIwSUpXdFZFQmE5T2hUUFBhRkstb1pOZENYZkg4WjBWa3NpSUZQWXBfSWJXUVFFSHRTZnA3c0R1UkZZOUtVSmZKaUxvMmJYM3A3RHBqbm1B?oc=5","date":"2025-10-14","type":"earnings","source":"Kyiv School of Economics","summary":"17 foreign companies fully liquidated or initiated the liquidation of their businesses in Russia in Q3 2025 — one of the highest figures since the start of the full-scale invasion — KSE Institute - Ky","headline":"17 foreign companies fully liquidated or initiated the liquidation of their businesses in Russia in Q3 2025 — one of the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQNDhWS2lZWDIyZXJPZHNPV0ptVTdPVExoa3J1WGhFWDFyN054cThZZElaYzFJLXhuMmtFWUd3MXdkdFdYckNWeXE4eXpGdlBwQ1U4X2xKMWQxU01mZjdaYkJueG5DcWFsQ3dZUjNQcl9aU0RPY1Q5VjY0Mnd0bTdGNUU3c3Q4OWV5SldndzdyUmhnNUFlM2hhX2FOcXI1Wmw5a1BBTmIwS29mTXJqMmRvSkNGZGtPNllLM2c?oc=5","date":"2025-08-29","type":"trial","source":"Investing News Network","summary":"Invion CEO Maps Path to Peer-level Valuation as Momentum for Cancer Treatment Trials Builds - Investing News Network","headline":"Invion CEO Maps Path to Peer-level Valuation as Momentum for Cancer Treatment Trials Builds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxNRXZOQ0ZfeWxMbVJVY1BlX09zNmdGRnZucUUtZlFuem9iRmVlWWpkdk1MYjZjeGM0VUE1VUhxMy1vY1FVNmk0NXhVdnZmZVdESXhhRGVvM1lYcUE4dHZ6VVN2Ynd1c2hzY2FNU2lKRjhMd0syUnRuQnZVR0JZVjRyVjk0Mk5XazBRSm4tUnlBb3k0ZzNwVl83bWxQNmRyRm03bVNXNHBCYlZiTXNTV0M0OFA1ZEJNS0JKX2ZKalRXTHVfZy1WbGllcFJSRlFXTGZDN1VXTkgxR1FFTmo1V0ZqMGt1WmQxLWt3eF84VUQ0WVI?oc=5","date":"2024-08-14","type":"pipeline","source":"Business and Human Rights Centre","summary":"Lilly, Novartis join drugmakers in scaling back operations in Russia in response to invasion of Ukraine - Business and Human Rights Centre","headline":"Lilly, Novartis join drugmakers in scaling back operations in Russia in response to invasion of Ukraine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNWGc3SUpoVWFzZWIyQnVSVmEzcmh3WnBzejlWT1BIQXZ2Z0VWRzBjSV9JNG52Y2FaWFNndnY4Y3BQVVY3czZheWFtNjM1VmRLOWF3ZURSWFplNUF2ZG9NWjJSeXpYcW5DVzNEbTVDR0FkdTN0X0l6dzFHaGdNcjBIZlpVelQ2NF9IY3daSFdkdVBfcTVWanc?oc=5","date":"2024-04-16","type":"trial","source":"Pharma Voice","summary":"Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back? - Pharma Voice","headline":"Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9xeUh1S05OSFFubW9uZGxZVTFteEw3Q0oxRC1STWxVRk53aGNVcEtjcnhpSUhHSnB0Q21FZW9kZEprWk9jNkttS2ZHblNibnp0Y1hNM3hFUklJODRzaHow?oc=5","date":"2023-11-03","type":"pipeline","source":"Nature","summary":"Wnt activation disturbs cell competition and causes diffuse invasion of transformed cells through NF-κB-MMP21 pathway - Nature","headline":"Wnt activation disturbs cell competition and causes diffuse invasion of transformed cells through NF-κB-MMP21 pathway","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFA4VFJjMHF1VnNleThITHVuUk1EOEpGVTBxYnY3X09QQV82a3Job2hvclR6a0lBNTU2d0d4VlVJTnJ0WS1FdWhTR0NEZ0dka2N6S2RYM2pCRWg3emVoc1ltcDAxVVV0aDRaYmQ3Nw?oc=5","date":"2023-04-10","type":"trial","source":"Harvard Business Review","summary":"Case Study: Is It Time to Exit Russia? - Harvard Business Review","headline":"Case Study: Is It Time to Exit Russia?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNQ3VaSm5CczhIYzd4cHM1UlhjVEI1a1p3LTB2clVYYlFwaUtQYnlWc2NkN0VWaDhNYVVEYVc3cHh5cXZQUWgzdm91VDZaQnN1eGd5cGdKSHFUckxvOUs4R0V1ZWFEeFo1T0tJUGNUalFpWjdPa09iTHEyMlkxYjFTLVVBSjRtaTFzeVVJMk1zb2otUGpScGxleExsQkxMWW9BTE12T0hscFdSOXVXemp3bUtwdjBVeXJHWkxLVDhBYno0eHJDQTM2SDg3LWx0Tm9WSF9SVA?oc=5","date":"2022-03-11","type":"trial","source":"Reuters","summary":"Drugmakers look to help Ukrainians in drug trials after Russian invasion - Reuters","headline":"Drugmakers look to help Ukrainians in drug trials after Russian invasion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNVkpnU1ppRkNIUEVDZlZCUFhOZjBtTGJUX2ZFQjRHVHZEczduQzJIUEJTTTZOZWNjcnBwTU9nZU5reUJTVE15NWFSTWp2ZDIzaWxSRUVGWUNlQkFXb18yQ1dqMHpMOFV5Tkw5NHpvQWFSdklLX3Y2OEhnTFk2a18wVVBERzlhNnQxdjZ3ZGY2SktpdzNYYV9QazJQaWtqQQ?oc=5","date":"2021-06-09","type":"pipeline","source":"ABC13 Houston","summary":"Houston CEO at center of $134M fraud case victim of armed home invasion - ABC13 Houston","headline":"Houston CEO at center of $134M fraud case victim of armed home invasion - ABC13 Houston","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNM2dTNEtxM2lqcWxuemdPeWNRSW5VS1FWMGY2RVpxcE5KNzZoUnRtdjlZemdXTkpvbFdveXBBbWFZVXVHb2phVWhORUdDS3daNkEyaFptazlMdS1oU21hT1lOVGt4Mk93Mlp4cDVaTlpaUnZEVnhWUkZud2VzcFl1TUdIS3ZkYmR4V1VKMHVVVEhYc3loTlR6UTJEMnRUTDBXa1Q3SHNnbE13Nm1BdGJsRkZ3UkJPdXdR?oc=5","date":"2015-03-20","type":"pipeline","source":"delawareonline.com","summary":"Invion betting big on future drug breakthroughs - delawareonline.com","headline":"Invion betting big on future drug breakthroughs","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}